India's Mankind Pharma Ltd posted a 66% jump in June-quarter profit on Wednesday, ... Mankind Pharma logo is seen in this illustration taken, May 9, 2023.

Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV) from private equity investor Advent International in a Rs136.3bn ($1.6bn ...

Indian pharmaceutical company Mankind Pharma Ltd is seeking a valuation of 432.64 billion rupees ($5.27 billion) at the upper end of a price band it set for its initial public offering (IPO) on ...

Mankind Pharma, which owned brands such as the Manforce condom and pregnancy testing kit Prega News, had reported a consolidated net profit of 14.33 billion rupees for the year ended March 31, ...

Mankind Pharma Ltd said it had entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise ...

Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat Serums and Vaccines for $1.6 billion from Boston-based private equity firm Advent ...

Mankind had a 4.4% share of the highly fragmented domestic pharma market as of end-August. Analyst Shah says moving into the top three “is not an impossible goal.” But Mankind faces challenges.

On May 15, Mankind Pharma will report earnings from Q4.Wall Street analysts are expecting earnings per share of INR 9.62.Go here to track Mankind ...